- WB
Lab
Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)
Lane 1 : Wild-type RAW 264.7 cell lysate 20μg.
Lane 2 : PRKAA1 knockout RAW 264.7 cell lysate 20 μg.
Lane 3 : Mouse Liver cell lysate 20 μg.
Lane 4 : Neuro2A cell lysate 20 μg.
False colour image of Western blot : Anti-AMPK alpha 1 antibody [2B7] staining at 1/500 dilution, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution shown in red. In Western blot ab110036 was shown to bind specifically to AMPK alpha 1. A band was observed at 64 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PRKAA1 knockout cell line ab280055 (knockout cell lysate ab280114). To generate this image wild-type and PRKAA1 knockout RAW 264.7 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.
All lanes:
Western blot - Anti-AMPK alpha 1 antibody [2B7] (<a href='/ko/products/primary-antibodies/ampk-alpha-1-antibody-2b7-ab110036'>ab110036</a>) at 1/500 dilution
Lane 1:
Wild-type RAW 264.7 cell lysate at 20 µg
Lane 2:
PRKAA1 knockout RAW 264.7 cell lysate at 20 µg
Lane 2:
Western blot - Mouse PRKAA1 knockout RAW 264.7 cell line (<a href='/ko/products/cell-lines/mouse-prkaa1-knockout-raw-2647-cell-line-ab280055'>ab280055</a>)
Lane 3:
Mouse Liver cell lysate at 20 µg
Lane 4:
Neuro2A cell lysate at 20 µg
Predicted band size: 64 kDa
Observed band size: 64 kDa
false
- Sanger seq
Supplier Data
Sanger Sequencing - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)
Mouse Prkaa1 KO in Raw264.7 Cells with 2 bp deletion in Exon 4
- WB
Lab
Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (AB280114)
Lane 1 : Wild-type RAW 264.7 cell lysate 20 μg
Lane 2 : PRKAA1 knockout RAW 264.7 cell lysate 20 μg
Lane 3 : Mouse Liver cell lysate 20 μg
Lane 4 : Neuro2A cell lysate 20 μg
False colour image of Western blot : Anti-AMPK alpha 1 antibody [Y365] staining at 1/1000 dilution shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution shown in red. In Western blot ab32047 was shown to bind specifically to AMPK alpha 1. A band was observed at 64 kDa in wild-type RAW 264.7 cell lysates with no signal observed at this size in PRKAA1 knockout cell line ab280055 (knockout cell lysate ab280114). To generate this image wild-type and PRKAA1 knockout RAW 264.7 cell lysates were analysed. First samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T incubated with secondary antibodies for 1 h at room temperature washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-AMPK alpha 1 antibody [Y365] (<a href='/ko/products/primary-antibodies/ampk-alpha-1-antibody-y365-ab32047'>ab32047</a>) at 1/1000 dilution
Lane 1:
Wild-type RAW 264.7 cell lysate at 20 µg
Lane 2:
Western blot - Mouse PRKAA1 knockout RAW 264.7 cell lysate (ab280114) at 20 µg
Lane 3:
Mouse Liver cell lysate at 20 µg
Lane 4:
Neuro2A cell lysate at 20 µg
Predicted band size: 64 kDa
Observed band size: 64 kDa
false
Reactivity 정보
제품 세부 정보
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
제품 구성
특성 및 보관 정보
유전자명
유전자 편집 종류
유전자 편집 방식
Knockout 검증
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PRKAA1 acts as an energy sensor and regulator in cells. As part of the AMPK heterotrimeric complex it regulates energy metabolism by phosphorylating various substrates involved in lipid glucose and protein metabolism. PRKAA1 activation results in increased glucose uptake fatty acid oxidation and mitochondrial biogenesis while inhibiting the synthesis of fatty acids cholesterol and triglycerides. This protein plays a significant role in maintaining cellular energy homeostasis and adapting to metabolic stress.
Pathways
PRKAA1 links to both the mTOR signaling pathway and the insulin signaling pathway. In the mTOR pathway it interacts with proteins such as TSC2 and Raptor leading to the inhibition of mTORC1 activity. In the insulin signaling pathway PRKAA1 affects the phosphorylation state of proteins involved in glucose homeostasis. PRKAA1’s regulation of these pathways highlights its importance in metabolic processes and energy balance.
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Male
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com